Old Web
English
Sign In
Acemap
>
authorDetail
>
Bernard W. Parker
Bernard W. Parker
Georgetown University
Medicine
Partial thromboplastin time
Pentosan polysulfate
Heparinoid
Chemotherapy
5
Papers
45
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Establishing a Primary Care Alliance for Conducting Cancer Prevention Clinical Research at Community Sites.
2021
Cancer Prevention Research
Bernard W. Parker
Barbara L. McAneny
Edith P. Mitchell
Ana Maria Lopez
Sandra A. Russo
Pamela Maxwell
Leslie G. Ford
Worta McCaskill-Stevens
Show All
Source
Cite
Save
Citations (0)
Abstract D079: Oncologists’ approach in managing pre-existing chronic comorbidities during patients’ active cancer treatment
2020
Cancer Epidemiology, Biomarkers & Prevention
Dudith Pierre-Victor
Iman K. Martin
Brenda A. Adjei
Mary Shaw-Ridley
Bruce D. Rapkin
Marjorie J. Good
Diane St. Germain
Bernard W. Parker
Worta McCaskill-Stevens
Show All
Source
Cite
Save
Citations (0)
Oncologists’ perceived confidence in managing pre-existing chronic comorbidities during patients’ active cancer treatment.
2019
Journal of Clinical Oncology
Dudith Pierre-Victor
Iman K. Martin
Brenda A. Adjei
Mary Shaw-Ridley
Bruce D. Rapkin
Marge Good
Diane St. Germain
Bernard W. Parker
Worta McCaskill-Stevens
Show All
Source
Cite
Save
Citations (0)
Phase I trial of pentosan polysulfate
1995
Investigational New Drugs
Sandra M. Swain
Bernard W. Parker
Anton Wellstein
Marc E. Lippman
Caryn Steakley
Robert J. DeLap
Show All
Source
Cite
Save
Citations (20)
Detectable inhibition of heparin-binding growth factor activity in sera from patients treated with pentosan polysulfate
1993
Journal of the National Cancer Institute
Bernard W. Parker
Sandra M. Swain
Gerhard Zugmaier
Robert L. DeLap
Marc E. Lippman
Anton Wellstein
Show All
Source
Cite
Save
Citations (25)
1